Zhejiang Runyang New Material Technology Co Ltd
SZSE:300920
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zhejiang Runyang New Material Technology Co Ltd
SZSE:300920
|
CN |
Balance Sheet
Balance Sheet Decomposition
Zhejiang Runyang New Material Technology Co Ltd
Zhejiang Runyang New Material Technology Co Ltd
Balance Sheet
Zhejiang Runyang New Material Technology Co Ltd
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
7
|
2
|
7
|
3
|
21
|
6
|
97
|
749
|
631
|
600
|
477
|
387
|
230
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
631
|
599
|
477
|
387
|
230
|
|
| Cash Equivalents |
7
|
2
|
6
|
3
|
21
|
6
|
97
|
749
|
0
|
1
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
84
|
0
|
0
|
0
|
0
|
0
|
10
|
51
|
|
| Total Receivables |
5
|
11
|
15
|
12
|
37
|
100
|
111
|
158
|
199
|
115
|
162
|
177
|
168
|
|
| Accounts Receivables |
3
|
6
|
9
|
11
|
32
|
73
|
82
|
105
|
120
|
72
|
125
|
124
|
131
|
|
| Other Receivables |
2
|
5
|
6
|
1
|
5
|
27
|
29
|
52
|
79
|
42
|
38
|
53
|
37
|
|
| Inventory |
3
|
4
|
3
|
5
|
17
|
27
|
15
|
38
|
95
|
73
|
68
|
78
|
91
|
|
| Other Current Assets |
1
|
2
|
1
|
1
|
4
|
13
|
4
|
1
|
7
|
8
|
4
|
17
|
32
|
|
| Total Current Assets |
16
|
19
|
25
|
20
|
79
|
231
|
227
|
947
|
932
|
796
|
711
|
657
|
572
|
|
| PP&E Net |
6
|
6
|
8
|
21
|
36
|
76
|
168
|
260
|
368
|
480
|
519
|
585
|
627
|
|
| PP&E Gross |
0
|
0
|
8
|
21
|
36
|
76
|
168
|
260
|
368
|
480
|
519
|
585
|
627
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
2
|
4
|
8
|
12
|
23
|
42
|
70
|
103
|
144
|
161
|
|
| Intangible Assets |
5
|
4
|
4
|
7
|
6
|
27
|
83
|
81
|
82
|
80
|
85
|
80
|
76
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
20
|
0
|
0
|
5
|
305
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
2
|
5
|
7
|
7
|
3
|
5
|
8
|
16
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
26
N/A
|
29
+9%
|
37
+28%
|
47
+28%
|
121
+155%
|
337
+178%
|
483
+44%
|
1 295
+168%
|
1 409
+9%
|
1 360
-3%
|
1 320
-3%
|
1 335
+1%
|
1 596
+20%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
4
|
7
|
7
|
6
|
20
|
36
|
41
|
35
|
52
|
58
|
57
|
63
|
61
|
|
| Accrued Liabilities |
0
|
0
|
1
|
0
|
5
|
7
|
7
|
11
|
11
|
8
|
10
|
14
|
12
|
|
| Short-Term Debt |
5
|
7
|
11
|
16
|
9
|
18
|
12
|
83
|
121
|
123
|
28
|
46
|
306
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
|
| Other Current Liabilities |
3
|
2
|
1
|
0
|
0
|
4
|
14
|
13
|
20
|
11
|
13
|
5
|
4
|
|
| Total Current Liabilities |
13
|
15
|
19
|
23
|
34
|
64
|
73
|
143
|
205
|
200
|
109
|
128
|
385
|
|
| Long-Term Debt |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
6
|
5
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
15
|
7
|
2
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
22
|
22
|
22
|
26
|
26
|
26
|
26
|
|
| Total Liabilities |
13
N/A
|
15
+20%
|
19
+23%
|
23
+23%
|
37
+59%
|
66
+79%
|
97
+48%
|
171
+76%
|
233
+37%
|
226
-3%
|
151
-33%
|
162
+7%
|
413
+156%
|
|
| Equity | ||||||||||||||
| Common Stock |
14
|
13
|
16
|
16
|
27
|
58
|
75
|
100
|
100
|
100
|
100
|
100
|
100
|
|
| Retained Earnings |
0
|
0
|
2
|
8
|
29
|
116
|
232
|
359
|
409
|
362
|
404
|
410
|
427
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
28
|
97
|
80
|
667
|
671
|
674
|
667
|
667
|
667
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
4
|
2
|
3
|
3
|
10
|
|
| Total Equity |
14
N/A
|
14
-1%
|
18
+35%
|
24
+33%
|
84
+248%
|
271
+222%
|
386
+43%
|
1 125
+191%
|
1 176
+5%
|
1 134
-4%
|
1 168
+3%
|
1 174
+0%
|
1 183
+1%
|
|
| Total Liabilities & Equity |
26
N/A
|
29
+9%
|
37
+28%
|
47
+28%
|
121
+155%
|
337
+178%
|
483
+44%
|
1 295
+168%
|
1 409
+9%
|
1 360
-3%
|
1 320
-3%
|
1 335
+1%
|
1 596
+20%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
14
|
13
|
16
|
16
|
27
|
58
|
75
|
100
|
100
|
100
|
100
|
100
|
100
|
|